Overview

Opioid and Cannabinoid Pharmacokinetic Interactions

Status:
Completed
Trial end date:
2009-03-01
Target enrollment:
Participant gender:
Summary
We are conducting a study to assess whether smoking marijuana affects the safety of prescribed opioids in patients treated for chronic pain. This study will assess whether smoking cannabis affects the absorption, distribution, metabolism and excretion of widely used opioid analgesics. We propose to do this by investigating the effects of smoked cannabis in subjects prescribed morphine or oxycodone for chronic pain. We will also assess the clinical safety of cannabinoids and these opioids by monitoring the short-term side effects associated with combined therapy.
Phase:
Phase 1
Details
Lead Sponsor:
University of California, San Francisco
Collaborator:
National Institute on Drug Abuse (NIDA)